Form 4: Globus Medical Director Sells Shares
Insider Transaction (Form 4)
Stephen T Zarrilli, a Director of Globus Medical Inc, sold 25,000 shares of common stock on August 18, 2026 for $87.04 per share.
Summary
- Option exercise/conversion: acquired 25,000 Class A Common Stock at $53.27 ($1,331,750) on August 18, 2026; holds 25,000 after (Direct).
- Open-market sale: disposed of 25,000 Class A Common Stock at $87.04 ($2,175,965) on August 18, 2026 (Direct).
- Option exercise/conversion: disposed of 25,000 Stock Option (Right to Buy Class A Common Stock) on August 18, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,175,965 of stock on the open market.
Insider Transactions
Stephen T Zarrilli — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Option exercise/conversion | Class A Common Stock | 25,000 | $53 | $1.3M | 25,000 |
| 2026-08-18 | Open-market sale | Class A Common Stock | 25,000 | $87 | $2.2M | 0 |
| 2026-08-18 | Option exercise/conversion | Stock Option (Right to Buy Class A Common Stock) | 25,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Option exercise/conversion (25,000 shares) |
| 2026-08-18 | Open-market sale (25,000 shares) |
| 2026-08-18 | Option exercise/conversion (25,000 shares) |
Keywords
insider transaction, Form 4, GMED, GLOBUS MEDICAL INC, bearish, Stephen T Zarrilli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.